Your browser doesn't support javascript.
loading
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu, Hai-Dong; Li, Hai-Liang; Huang, Ming-Sheng; Yang, Wei-Zhu; Yin, Guo-Wen; Zhong, Bin-Yan; Sun, Jun-Hui; Jin, Zhi-Cheng; Chen, Jian-Jian; Ge, Nai-Jian; Ding, Wen-Bin; Li, Wen-Hui; Huang, Jin-Hua; Mu, Wei; Gu, Shan-Zhi; Li, Jia-Ping; Zhao, Hui; Wen, Shu-Wei; Lei, Yan-Ming; Song, Yu-Sheng; Yuan, Chun-Wang; Wang, Wei-Dong; Huang, Ming; Zhao, Wei; Wu, Jian-Bing; Wang, Song; Zhu, Xu; Han, Jian-Jun; Ren, Wei-Xin; Lu, Zai-Ming; Xing, Wen-Ge; Fan, Yong; Lin, Hai-Lan; Zhang, Zi-Shu; Xu, Guo-Hui; Hu, Wen-Hao; Tu, Qiang; Su, Hong-Ying; Zheng, Chuan-Sheng; Chen, Yong; Zhao, Xu-Ya; Fang, Zhu-Ting; Wang, Qi; Zhao, Jin-Wei; Xu, Ai-Bing; Xu, Jian; Wu, Qing-Hua; Niu, Huan-Zhang; Wang, Jian; Dai, Feng.
Afiliação
  • Zhu HD; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Li HL; Department of Minimally invasive Intervention, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, China.
  • Huang MS; Department of Interventional Radiology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Yang WZ; Department of Interventional Radiology, Union Hospital of Fujian Medical University, Fuzhou, 350001, China.
  • Yin GW; Department of Interventional Radiology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Zhong BY; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215006, China.
  • Sun JH; Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Jin ZC; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Chen JJ; Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
  • Ge NJ; Department of Interventional Radiology, Eastern Hospital of Hepatobiliary Surgery, Navy Medical University (Second Military Medical University), Shanghai, 200438, China.
  • Ding WB; Department of Interventional Radiology, Nantong First People's Hospital, Nantong, 226001, China.
  • Li WH; Department of Interventional Radiology, Yancheng Third People's Hospital, Yancheng, 224008, China.
  • Huang JH; Department of Minimally Invasive Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Mu W; Department of Vascular Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
  • Gu SZ; Department of Interventional Radiology, Hunan Cancer Hospital, Changsha, 410031, China.
  • Li JP; Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
  • Zhao H; Department of Interventional Radiology, The Hospital of Nantong University, Nantong, 226001, China.
  • Wen SW; Department of Interventional Therapy, Shanxi Tumor Hospital, Taiyuan, 030001, China.
  • Lei YM; Department of Interventional Radiology, Tibet Autonomous Region People's Hospital, Lhasa, 850000, China.
  • Song YS; Department of Interventional Radiology, Ganzhou People's Hospital, Ganzhou, 341000, China.
  • Yuan CW; Center of Interventional Oncology and Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
  • Wang WD; Department of Interventional Radiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, China.
  • Huang M; Department of Minimally Invasive Interventional Therapy, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, China.
  • Zhao W; Department of Radiology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.
  • Wu JB; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Wang S; Department of Interventional Radiology, Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
  • Zhu X; Department of Interventional Therapy, Peking University Cancer Hospital and Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, 100142, China.
  • Han JJ; Department of Interventional Radiology, Affiliated Cancer Hospital of Shandong First Medical University, Jinan, 250117, China.
  • Ren WX; Interventional Therapy Center, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011, China.
  • Lu ZM; Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, 830011, China.
  • Xing WG; Department of Interventional Oncology, Tianjin Medical University Cancer Hospital, Tianjin, 300060, China.
  • Fan Y; Department of Radiology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  • Lin HL; Department of Tumor Interventional Therapy, Fujian Cancer Hospital, Fuzhou, 350014, China.
  • Zhang ZS; Department of Radiology, The Second Xiangya Hospital, Changsha, 410011, China.
  • Xu GH; Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Chengdu, 610041, China.
  • Hu WH; Department of Interventional Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Tu Q; Department of Hepatobiliary Oncology Surgery, Department of Interventional Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, 330029, China.
  • Su HY; Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang, 110001, China.
  • Zheng CS; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 110001, China.
  • Chen Y; Department of Interventional Radiology, General hospital of Ningxia Medical University, Yinchuan, 110001, China.
  • Zhao XY; Department of Interventional Radiology, Guizhou Cancer Hospital, Guiyang, 550000, China.
  • Fang ZT; Department of Interventional Radiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
  • Wang Q; Department of Interventional Radiology, Third Affiliated Hospital of Soochow University, Changzhou First Hospital, Changzhou, 213004, China.
  • Zhao JW; Department of Interventional and Vascular Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China.
  • Xu AB; Department of Interventional Therapy, Nantong Tumor Hospital, Nantong, 226006, China.
  • Xu J; Department of Interventional Therapy, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China.
  • Wu QH; Department of Interventional Radiology, Affiliated Hospital of Jiangnan University, Wuxi, 214122, China.
  • Niu HZ; Department of Interventional Radiology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
  • Wang J; Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, 100034, China.
  • Dai F; Department of Interventional Radiology, The Second Hospital of Nanjing, Nanjing, 210000, China.
Signal Transduct Target Ther ; 8(1): 58, 2023 02 08.
Article em En | MEDLINE | ID: mdl-36750721
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article